In the News

When Ilia Malinin steps onto the ice in Milano–Cortina, he is not only competing for medals. He is also competing in the modern attention economy, where a single performance can drive millions of views, followers, and (sometimes) sponsorship inquiries. That visibility is a commercial opportunity, but it is also a legal and contractual risk, becau…

On January 28, 2026, a federal court in Nebraska overturned the United States Citizenship and Immigration Services (USCIS)’s denial of an EB-1A extraordinary ability petition in Mukherji v. Miller and sent the case back to USCIS with instructions to approve it. The decision questions the way USCIS commonly evaluates EB-1A petitions after an appli…

Super Bowl LX is almost here, with the final matchup set in the Bay Area on February 8 between the Seattle Seahawks and the New England Patriots.  Each year, more than 120 million viewers tune in, making it the most-watched television event in the United States. Some are season-long fans, and others tune in for the commercials.  But the g…

Biotech startups, like all emerging companies, face a gauntlet of operational and financial challenges inherent to the startup ecosystem. Yet, their journey is uniquely complicated by industry-specific hurdles that set them apart from ventures in other sectors. At the heart of a biotech company lies its intellectual property (IP)—a cornerstone th…

Canadian citizens often enjoy smoother entry to the United States than many other travelers, but “smooth” does not mean “automatic.” Misunderstandings can lead to shortened admissions, unexpected compliance obligations, or complications at the border. However, taking the proper precautions before traveling can help reduce travel risk. Visa …